Scientists Find Key Protein That Suppresses Prostate Cancer Growth In The Laboratory
2/01/2011

Cancer researchers have discovered an important protein, produced naturally inside cells, that appears to suppress the growth of prostate cancer cells in the laboratory. The findings, published tomorrow in the journal Cancer Research, offer promising leads for research towards new treatments...

Novel Immune System-Based Gene Therapy Induces Strong Responses In Metastatic Melanoma, Sarcoma
2/01/2011

Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers...

XYTOS Introduces Their Cancer Diagnostic Fluorescent Scanning Technique
1/31/2011

XYTOS (the "Company") (OTC: XYTS) is excited to announce their Cancer Diagnostic Fluorescent Scanning Technique. The XYTOS procedure is a major achievement in the fight against cancer. XYTOS expects that their fluorescent scanning technique will soon become the standard for diagnosing Breast and Skin Cancer...

For Prostate Cancer Patients, Pre-Surgical Stress Management Boosts Immune Function, Lowers Mood Disturbance
1/31/2011

Practicing stress management techniques before prostate cancer surgery may help activate the body's immune response leading to quicker recovery, as well as aid in lowering mood disturbance, according to a new study by researchers at The University of Texas MD Anderson Cancer Center. The study is published in the February/March edition of the journal Psychosomatic Medicine...

Study Seeks Volunteers With Prostate Cancer To Measure Safety Of Robotic Stereotactic Radiosurgery
1/31/2011

The North Shore-LIJ Health System Department of Radiation Medicine announced it is seeking patients with early-stage (confined to the organ) prostate cancer to participate in a Phase I Research study. Subjects must be newly diagnosed and considered lower risk, with a Gleason score of equal to or less than 7 and a PSA level below 10...

Lightly Steamed Broccoli Has Powerful Anticancer Enzyme Myrosinase
1/30/2011

Broccoli can significantly reduce your risk of developing cancers if you don't destroy the enzyme myrosinase - you can only do this effectively by steaming the vegetable lightly. Overcook it and the health benefits will be considerably undermined, researchers from the University of Illinois wrote in Nutrition and Cancer...

Early Successful Readout Of Tarceva Study In A Distinct Form Of Lung Cancer
1/30/2011

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint...

APP Pharmaceuticals Announces Agreement With Teva Pharmaceuticals To Manufacture And Market Gemcitabine HCI For Injection
1/28/2011

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced that it has entered into a commercialization, manufacture and supply agreement with Teva Pharmaceutical USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd., (NASDAQ:TEVA) to manufacture and market Gemcitabine HCI for Injection...

Study Suggests New Ovarian Cancer Treatment Option
1/28/2011

A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option - one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors...

Cervical Cancer Jab Uptake Increases, UK
1/28/2011

Over 84 per cent of girls aged 13-14 have helped protect themselves against cervical cancer by getting all three doses of the HPV vaccine and more than four million doses of the vaccine have been given in the first two years of the programme, Public Health Minister Anne Milton announced today...